Trial Profile
Heart and Estrogen-Progestin Replacement Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2014
Price :
$35
*
At a glance
- Drugs Conjugated estrogens/medroxyprogesterone (Primary)
- Indications Coronary disorders
- Focus Therapeutic Use
- Acronyms HERS
- 19 Jun 2014 New trial record